Table 4.
Statistic tests of FPG level at 24–28th of gestational weeks in diagnosing GDM
FPG (mg/dL) at OGTT | No of women < threshold, n (%) | Area | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | LR + | LR − |
---|---|---|---|---|---|---|---|---|
75 | 269 | 0.657 | 99.2 | 32.3 | 17.6 | 99.6 | 1.46 | 0.02 |
80 | 524 | 0.801 | 97.5 | 62.7 | 27.6 | 99.4 | 2.61 | 0.03 |
85 | 702 | 0.903 | 96.7 | 84 | 46.8 | 99.4 | 6.04 | 0.03 |
90 | 828 | 0.946 | 90.9 | 98.3 | 88.7 | 98.7 | 53.47 | 0.09 |
92 | 847 | 0.934 | 86.8 | 100 | 100 | 98.1 | – | 0.13 |
FPG fasting plasma glucose; PPV positive predictive value; NPV negative predictive value; LR likelihood ratio